SCHEMBL18929928

SCHEMBL18929928

CC(C)c1ccc(F)cc1OCF

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH4 Q9H3N8 1/20 0.35
CYP2D6 P10635 1/20 0.35
HTR1A P08908 4/20 0.34
HTR7 P34969 4/20 0.34
P2RY1 P47900 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ADRB2 P07550 1/20 0.34
NPBWR1 P48145 1/20 0.34
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908241 0.87 HRH4 (0.45) ALDH1A1TDP1KDM4EL3MBTL1CYP1A2
SCHEMBL9945958 0.82 ALDH1A1 (0.44) ALDH1A1TDP1KDM4EL3MBTL1CYP1A2
SCHEMBL24869054 0.81 CYP1A2 (0.42) ALDH1A1TDP1KDM4EL3MBTL1CYP1A2
SCHEMBL25944306 0.81 RXRA (0.45) ALDH1A1KDM4EL3MBTL1CYP1A2CYP2C19
SCHEMBL24869064 0.81 ALDH1A1 (0.44) ALDH1A1TDP1KDM4EL3MBTL1CYP1A2
SCHEMBL14456037 0.80 ALDH1A1 (0.36) ALDH1A1TDP1KDM4EL3MBTL1MEN1
SCHEMBL24869124 0.80 ALOX5AP (0.39) ALDH1A1TDP1KDM4EL3MBTL1MEN1
SCHEMBL21754757 0.80 HTR2A (0.48) HTR1AHTR7DRD2HTR6ADRA1D
SCHEMBL765434 0.79 GAA (0.43) KDM4EL3MBTL1CYP1A2CYP2C19MEN1
SCHEMBL10918185 0.78 PTGS1 (0.36) ALDH1A1TDP1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2922841-B1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL MYERS SQUIBB CO (US) 2017-06-07 EP disclosed